Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "Hyperimmunoglobulinemia D with periodic fever"

Clinical trialCLINICALTRIALSToday

New Clinical Trial: Bridges2Scale: Testing Implementation Strategies (NCT06347146)

Researchers are testing two different ways to bring a program called Bridges to more schools in Uganda. Bridges helps young people (ages 11-17) who are living with HIV/AIDS learn about their health and get support. This study will compare whether a standard approach or an enhanced approach works better at getting the program into 48 schools in the Greater Masaka region.

WHY IT MATTERSThis trial is testing implementation strategies for HIV/AIDS support programs in adolescents and youth in Uganda, which could improve how effective HIV care and education reaches young people in resource-limited settings.
👁 Watch this spaceHIV/AIDSRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases